These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 38282238)

  • 21. Gene-Environment Interactions in Multiple Sclerosis: A UK Biobank Study.
    Jacobs BM; Noyce AJ; Bestwick J; Belete D; Giovannoni G; Dobson R
    Neurol Neuroimmunol Neuroinflamm; 2021 Jul; 8(4):. PubMed ID: 34049995
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum Glial Fibrillary Acidic Protein Compared With Neurofilament Light Chain as a Biomarker for Disease Progression in Multiple Sclerosis.
    Meier S; Willemse EAJ; Schaedelin S; Oechtering J; Lorscheider J; Melie-Garcia L; Cagol A; Barakovic M; Galbusera R; Subramaniam S; Barro C; Abdelhak A; Thebault S; Achtnichts L; Lalive P; Müller S; Pot C; Salmen A; Disanto G; Zecca C; D'Souza M; Orleth A; Khalil M; Buchmann A; Du Pasquier R; Yaldizli Ö; Derfuss T; Berger K; Hermesdorf M; Wiendl H; Piehl F; Battaglini M; Fischer U; Kappos L; Gobbi C; Granziera C; Bridel C; Leppert D; Maleska Maceski A; Benkert P; Kuhle J
    JAMA Neurol; 2023 Mar; 80(3):287-297. PubMed ID: 36745446
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identifying proteomic risk factors for cancer using prospective and exome analyses of 1463 circulating proteins and risk of 19 cancers in the UK Biobank.
    Papier K; Atkins JR; Tong TYN; Gaitskell K; Desai T; Ogamba CF; Parsaeian M; Reeves GK; Mills IG; Key TJ; Smith-Byrne K; Travis RC
    Nat Commun; 2024 May; 15(1):4010. PubMed ID: 38750076
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma proteomic associations with genetics and health in the UK Biobank.
    Sun BB; Chiou J; Traylor M; Benner C; Hsu YH; Richardson TG; Surendran P; Mahajan A; Robins C; Vasquez-Grinnell SG; Hou L; Kvikstad EM; Burren OS; Davitte J; Ferber KL; Gillies CE; Hedman ÅK; Hu S; Lin T; Mikkilineni R; Pendergrass RK; Pickering C; Prins B; Baird D; Chen CY; Ward LD; Deaton AM; Welsh S; Willis CM; Lehner N; Arnold M; Wörheide MA; Suhre K; Kastenmüller G; Sethi A; Cule M; Raj A; ; ; ; ; ; ; ; ; ; Burkitt-Gray L; Melamud E; Black MH; Fauman EB; Howson JMM; Kang HM; McCarthy MI; Nioi P; Petrovski S; Scott RA; Smith EN; Szalma S; Waterworth DM; Mitnaul LJ; Szustakowski JD; Gibson BW; Miller MR; Whelan CD
    Nature; 2023 Oct; 622(7982):329-338. PubMed ID: 37794186
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum glial fibrillary acidic protein correlates with multiple sclerosis disease severity.
    Högel H; Rissanen E; Barro C; Matilainen M; Nylund M; Kuhle J; Airas L
    Mult Scler; 2020 Feb; 26(2):210-219. PubMed ID: 30570436
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Brain alterations in regions associated with end-organ diabetic microvascular disease in diabetes mellitus: A UK Biobank study.
    Burgess J; de Bezenac C; Keller SS; Frank B; Petropoulos IN; Garcia-Finana M; Jackson TL; Kirthi V; Cuthbertson DJ; Selvarajah D; Tesfaye S; Alam U
    Diabetes Metab Res Rev; 2024 Feb; 40(2):e3772. PubMed ID: 38363054
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Markers for different glial cell responses in multiple sclerosis: clinical and pathological correlations.
    Petzold A; Eikelenboom MJ; Gveric D; Keir G; Chapman M; Lazeron RH; Cuzner ML; Polman CH; Uitdehaag BM; Thompson EJ; Giovannoni G
    Brain; 2002 Jul; 125(Pt 7):1462-73. PubMed ID: 12076997
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rare variant associations with plasma protein levels in the UK Biobank.
    Dhindsa RS; Burren OS; Sun BB; Prins BP; Matelska D; Wheeler E; Mitchell J; Oerton E; Hristova VA; Smith KR; Carss K; Wasilewski S; Harper AR; Paul DS; Fabre MA; Runz H; Viollet C; Challis B; Platt A; ; Vitsios D; Ashley EA; Whelan CD; Pangalos MN; Wang Q; Petrovski S
    Nature; 2023 Oct; 622(7982):339-347. PubMed ID: 37794183
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Associations between multimorbidity and adverse health outcomes in UK Biobank and the SAIL Databank: A comparison of longitudinal cohort studies.
    Hanlon P; Jani BD; Nicholl B; Lewsey J; McAllister DA; Mair FS
    PLoS Med; 2022 Mar; 19(3):e1003931. PubMed ID: 35255092
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Appraising associations between signature lipidomic biomarkers and digestive system cancer risk: novel evidences from a prospective cohort study of UK Biobank and Mendelian randomization analyses.
    Sun Y; Cao D; Zhang Y; Wu Y; Jia Z; Cui Y; Li D; Cao X; Jiang J
    Lipids Health Dis; 2024 Feb; 23(1):61. PubMed ID: 38419059
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glial fibrillary acidic protein and multiple sclerosis progression independent of acute inflammation.
    Jiang X; Shen C; Teunissen CE; Wessels M; Zetterberg H; Giovannoni G; Singh CM; Caba B; Elliott C; Fisher E; de Moor C; Belachew S; Gafson AR
    Mult Scler; 2023 Aug; 29(9):1070-1079. PubMed ID: 37317870
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma glial fibrillary acidic protein and neurofilament light chain in relation to disability worsening in multiple sclerosis.
    Pauwels A; Van Schependom J; Devolder L; Van Remoortel A; Nagels G; Bjerke M; D'hooghe MB
    Mult Scler; 2022 Oct; 28(11):1685-1696. PubMed ID: 36059263
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association Between Serum MicroRNAs and Magnetic Resonance Imaging Measures of Multiple Sclerosis Severity.
    Regev K; Healy BC; Khalid F; Paul A; Chu R; Tauhid S; Tummala S; Diaz-Cruz C; Raheja R; Mazzola MA; von Glehn F; Kivisakk P; Dupuy SL; Kim G; Chitnis T; Weiner HL; Gandhi R; Bakshi R
    JAMA Neurol; 2017 Mar; 74(3):275-285. PubMed ID: 28114622
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NfL and GFAP in serum are associated with microstructural brain damage in progressive multiple sclerosis.
    Ammitzbøll C; Dyrby TB; Börnsen L; Schreiber K; Ratzer R; Romme Christensen J; Iversen P; Magyari M; Lundell H; Jensen PEH; Sørensen PS; Siebner HR; Sellebjerg F
    Mult Scler Relat Disord; 2023 Sep; 77():104854. PubMed ID: 37418931
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum glial fibrillary acidic protein in natalizumab-treated relapsing-remitting multiple sclerosis: An alternative to neurofilament light.
    Wessels MH; Van Lierop ZY; Noteboom S; Strijbis EM; Heijst JA; Van Kempen ZL; Moraal B; Barkhof F; Uitdehaag BM; Schoonheim MM; Killestein J; Teunissen CE
    Mult Scler; 2023 Sep; 29(10):1229-1239. PubMed ID: 37530045
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adherence to a healthy lifestyle and multiple sclerosis: a case-control study from the UK Biobank.
    Veronese N; Yang L; Piccio L; Smith L; Firth J; Marx W; Giannelli G; Caruso MG; Cisternino AM; Notarnicola M; Donghia R; Barbagallo M; Fontana L
    Nutr Neurosci; 2022 Jun; 25(6):1231-1239. PubMed ID: 33297884
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of technical and clinical utility of a bead-based flow cytometry platform for multiparametric phenotyping of CNS-derived extracellular vesicles.
    Brahmer A; Geiß C; Lygeraki A; Neuberger E; Tzaridis T; Nguyen TT; Luessi F; Régnier-Vigouroux A; Hartmann G; Simon P; Endres K; Bittner S; Reiners KS; Krämer-Albers EM
    Cell Commun Signal; 2023 Oct; 21(1):276. PubMed ID: 37803478
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Implementation and external validation of the Cambridge Multimorbidity Score in the UK Biobank cohort.
    Harrison H; Ip S; Renzi C; Li Y; Barclay M; Usher-Smith J; Lyratzopoulos G; Wood A; Antoniou AC
    BMC Med Res Methodol; 2024 Mar; 24(1):71. PubMed ID: 38509467
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence and demographics of multiple sclerosis-associated uveitis: a UK biobank study.
    Taylor TR; Jacobs BM; Giovannoni G; Petrushkin H; Dobson R
    Mult Scler Relat Disord; 2020 Aug; 43():102209. PubMed ID: 32480346
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic white matter lesion activity predicts clinical progression in primary progressive multiple sclerosis.
    Elliott C; Belachew S; Wolinsky JS; Hauser SL; Kappos L; Barkhof F; Bernasconi C; Fecker J; Model F; Wei W; Arnold DL
    Brain; 2019 Sep; 142(9):2787-2799. PubMed ID: 31497864
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.